SPOTLIGHT -
Q-Vis delays PMA application for laser
Daily use of 650-nm low-level red light for 1 year slowed progression of SER and AL
Claris Bio's journey toward treating neurotrophic keratitis
EyePoint Pharmaceutical's Phase 2 PAVIA falls short of primary endpoint
(EyePod) From idea to impact: Navigating ophthalmic innovation
Recurrent uveitis potential after COVID-19 vaccination in patients with a uveitis history
Video Journal of Cataract, Refractive, and Glaucoma Surgery: 40 years and counting